New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has extended the applicability of existing ceiling prices for orthopaedic knee implants used in knee replacement systems until January 15, 2027.

The extension comes while representations received from manufacturers and industry associations remain under consideration.

Through Order S.O. 6222(E), dated November 13, 2026, the authority has continued the existing ceiling price notification for a further period of up to two months beyond November 15, 2026, unless amended by a subsequent notification.

The NPPA originally notified ceiling prices for orthopaedic knee implants used in knee replacement systems through S.O. 2668(E), dated August 16, 2017. The applicability of the notification has been extended from time to time.

The last extension before the present order was issued through S.O. 5190(E), dated November 14, 2025, which was in force up to November 15, 2026. The latest order extends the validity of this notification in respect of the specified knee implants.

Setting out its decision, the authority stated:

"Now, therefore, the National Pharmaceutical Pricing Authority hereby extends the period for which the notification number S.O. 5190(E), dated the 14th November, 2025 shall be in force in respect of Orthopaedic Knee Implants for Knee Replacement System for a further period of up to two months beyond the 15th November, 2026, i.e., up to the 15th January, 2027, unless amended by a subsequent notification.”

The authority also clarified that Notes (b) to (t) of the original notification S.O. 2668(E), dated August 16, 2017, shall remain in force during the validity of the present order. Consequently, the extension continues both the existing ceiling price notification and the specified accompanying conditions.

The order records that representations received from manufacturers and industry associations are under the NPPA’s consideration. However, it does not specify the changes sought in those representations or announce revised ceiling price amounts.

To view the order, click the link below:

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .